Bridgeway Capital Management’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-53,900
| Closed | -$15K | – | 1497 |
|
|
2022
Q3 | $15K | Sell |
53,900
-16,000
| -23% | -$4.45K | ﹤0.01% | 1397 |
|
|
2022
Q2 | $25K | Sell |
69,900
-10,000
| -13% | -$3.58K | ﹤0.01% | 1308 |
|
|
2022
Q1 | $54K | Sell |
79,900
-43,000
| -35% | -$29.1K | ﹤0.01% | 1287 |
|
|
2021
Q4 | $284K | Sell |
122,900
-53,600
| -30% | -$124K | 0.01% | 1109 |
|
|
2021
Q3 | $808K | Buy |
176,500
+100,000
| +131% | +$458K | 0.02% | 885 |
|
|
2021
Q2 | $340K | Sell |
76,500
-106,500
| -58% | -$473K | 0.01% | 1182 |
|
|
2021
Q1 | $1.33M | Buy |
183,000
+98,600
| +117% | +$718K | 0.02% | 762 |
|
|
2020
Q4 | $644K | Hold |
84,400
| – | – | 0.01% | 865 |
|
|
2020
Q3 | $766K | Sell |
84,400
-44,000
| -34% | -$399K | 0.02% | 754 |
|
|
2020
Q2 | $1.09M | Buy |
128,400
+114,700
| +837% | +$970K | 0.02% | 620 |
|
|
2020
Q1 | $68K | Buy |
+13,700
| New | +$68K | ﹤0.01% | 1209 |
|